BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 35585141)

  • 1. Pediatric T-ALL type-1 and type-2 relapses develop along distinct pathways of clonal evolution.
    Richter-Pechańska P; Kunz JB; Rausch T; Erarslan-Uysal B; Bornhauser B; Frismantas V; Assenov Y; Zimmermann M; Happich M; von Knebel-Doeberitz C; von Neuhoff N; Köhler R; Stanulla M; Schrappe M; Cario G; Escherich G; Kirschner-Schwabe R; Eckert C; Avigad S; Pfister SM; Muckenthaler MU; Bourquin JP; Korbel JO; Kulozik AE
    Leukemia; 2022 Jul; 36(7):1759-1768. PubMed ID: 35585141
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The genomic landscape of teenage and young adult T-cell acute lymphoblastic leukemia.
    Mansur MB; Furness CL; Nakjang S; Enshaei A; Alpar D; Colman SM; Minto L; Irving J; Poole BV; Noronha EP; Savola S; Iqbal S; Gribben J; Pombo-de-Oliveira MS; Ford TM; Greaves MF; van Delft FW
    Cancer Med; 2021 Jul; 10(14):4864-4873. PubMed ID: 34080325
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clonal dynamics in pediatric B-cell precursor acute lymphoblastic leukemia with very early relapse.
    Antić Ž; Yu J; Bornhauser BC; Lelieveld SH; van der Ham CG; van Reijmersdal SV; Morgado L; Elitzur S; Bourquin JP; Cazzaniga G; Eckert C; Camós M; Sutton R; Cavé H; Moorman AV; Sonneveld E; Geurts van Kessel A; van Leeuwen FN; Hoogerbrugge PM; Waanders E; Kuiper RP
    Pediatr Blood Cancer; 2022 Jan; 69(1):e29361. PubMed ID: 34597466
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pediatric T-cell lymphoblastic leukemia evolves into relapse by clonal selection, acquisition of mutations and promoter hypomethylation.
    Kunz JB; Rausch T; Bandapalli OR; Eilers J; Pechanska P; Schuessele S; Assenov Y; Stütz AM; Kirschner-Schwabe R; Hof J; Eckert C; von Stackelberg A; Schrappe M; Stanulla M; Koehler R; Avigad S; Elitzur S; Handgretinger R; Benes V; Weischenfeldt J; Korbel JO; Muckenthaler MU; Kulozik AE
    Haematologica; 2015 Nov; 100(11):1442-50. PubMed ID: 26294725
    [TBL] [Abstract][Full Text] [Related]  

  • 5. NOTCH1 pathway activating mutations and clonal evolution in pediatric T-cell acute lymphoblastic leukemia.
    Kimura S; Seki M; Yoshida K; Shiraishi Y; Akiyama M; Koh K; Imamura T; Manabe A; Hayashi Y; Kobayashi M; Oka A; Miyano S; Ogawa S; Takita J
    Cancer Sci; 2019 Feb; 110(2):784-794. PubMed ID: 30387229
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapy-induced mutations drive the genomic landscape of relapsed acute lymphoblastic leukemia.
    Li B; Brady SW; Ma X; Shen S; Zhang Y; Li Y; Szlachta K; Dong L; Liu Y; Yang F; Wang N; Flasch DA; Myers MA; Mulder HL; Ding L; Liu Y; Tian L; Hagiwara K; Xu K; Zhou X; Sioson E; Wang T; Yang L; Zhao J; Zhang H; Shao Y; Sun H; Sun L; Cai J; Sun HY; Lin TN; Du L; Li H; Rusch M; Edmonson MN; Easton J; Zhu X; Zhang J; Cheng C; Raphael BJ; Tang J; Downing JR; Alexandrov LB; Zhou BS; Pui CH; Yang JJ; Zhang J
    Blood; 2020 Jan; 135(1):41-55. PubMed ID: 31697823
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Unravelling the Sequential Interplay of Mutational Mechanisms during Clonal Evolution in Relapsed Pediatric Acute Lymphoblastic Leukemia.
    Antić Ž; Lelieveld SH; van der Ham CG; Sonneveld E; Hoogerbrugge PM; Kuiper RP
    Genes (Basel); 2021 Feb; 12(2):. PubMed ID: 33540666
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutational landscape and patterns of clonal evolution in relapsed pediatric acute lymphoblastic leukemia.
    Waanders E; Gu Z; Dobson SM; Antić Ž; Crawford JC; Ma X; Edmonson MN; Payne-Turner D; van de Vorst M; Jongmans MCJ; McGuire I; Zhou X; Wang J; Shi L; Pounds S; Pei D; Cheng C; Song G; Fan Y; Shao Y; Rusch M; McCastlain K; Yu J; van Boxtel R; Blokzijl F; Iacobucci I; Roberts KG; Wen J; Wu G; Ma J; Easton J; Neale G; Olsen SR; Nichols KE; Pui CH; Zhang J; Evans WE; Relling MV; Yang JJ; Thomas PG; Dick JE; Kuiper RP; Mullighan CG
    Blood Cancer Discov; 2020 Jul; 1(1):96-111. PubMed ID: 32793890
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeted sequencing identifies associations between IL7R-JAK mutations and epigenetic modulators in T-cell acute lymphoblastic leukemia.
    Vicente C; Schwab C; Broux M; Geerdens E; Degryse S; Demeyer S; Lahortiga I; Elliott A; Chilton L; La Starza R; Mecucci C; Vandenberghe P; Goulden N; Vora A; Moorman AV; Soulier J; Harrison CJ; Clappier E; Cools J
    Haematologica; 2015 Oct; 100(10):1301-10. PubMed ID: 26206799
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Deep targeted sequencing in pediatric acute lymphoblastic leukemia unveils distinct mutational patterns between genetic subtypes and novel relapse-associated genes.
    Lindqvist CM; Lundmark A; Nordlund J; Freyhult E; Ekman D; Carlsson Almlöf J; Raine A; Övernäs E; Abrahamsson J; Frost BM; Grandér D; Heyman M; Palle J; Forestier E; Lönnerholm G; Berglund EC; Syvänen AC
    Oncotarget; 2016 Sep; 7(39):64071-64088. PubMed ID: 27590521
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rise and fall of subclones from diagnosis to relapse in pediatric B-acute lymphoblastic leukaemia.
    Ma X; Edmonson M; Yergeau D; Muzny DM; Hampton OA; Rusch M; Song G; Easton J; Harvey RC; Wheeler DA; Ma J; Doddapaneni H; Vadodaria B; Wu G; Nagahawatte P; Carroll WL; Chen IM; Gastier-Foster JM; Relling MV; Smith MA; Devidas M; Guidry Auvil JM; Downing JR; Loh ML; Willman CL; Gerhard DS; Mullighan CG; Hunger SP; Zhang J
    Nat Commun; 2015 Mar; 6():6604. PubMed ID: 25790293
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pediatric ALL relapses after allo-SCT show high individuality, clonal dynamics, selective pressure, and druggable targets.
    Hoell JI; Ginzel S; Kuhlen M; Kloetgen A; Gombert M; Fischer U; Hein D; Demir S; Stanulla M; Schrappe M; Zur Stadt U; Bader P; Babor F; Schuster F; Strahm B; Alten J; Moericke A; Escherich G; von Stackelberg A; Thiele R; McHardy AC; Peters C; Bornhauser B; Bourquin JP; Krause S; Enczmann J; Meyer LH; Eckert C; Borkhardt A; Meisel R
    Blood Adv; 2019 Oct; 3(20):3143-3156. PubMed ID: 31648313
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The evolution of relapse of adult T cell acute lymphoblastic leukemia.
    Sentís I; Gonzalez S; Genescà E; García-Hernández V; Muiños F; Gonzalez C; López-Arribillaga E; Gonzalez J; Fernandez-Ibarrondo L; Mularoni L; Espinosa L; Bellosillo B; Ribera JM; Bigas A; Gonzalez-Perez A; Lopez-Bigas N
    Genome Biol; 2020 Nov; 21(1):284. PubMed ID: 33225950
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Suppressors and activators of JAK-STAT signaling at diagnosis and relapse of acute lymphoblastic leukemia in Down syndrome.
    Schwartzman O; Savino AM; Gombert M; Palmi C; Cario G; Schrappe M; Eckert C; von Stackelberg A; Huang JY; Hameiri-Grossman M; Avigad S; Te Kronnie G; Geron I; Birger Y; Rein A; Zarfati G; Fischer U; Mukamel Z; Stanulla M; Biondi A; Cazzaniga G; Vetere A; Wagner BK; Chen Z; Chen SJ; Tanay A; Borkhardt A; Izraeli S
    Proc Natl Acad Sci U S A; 2017 May; 114(20):E4030-E4039. PubMed ID: 28461505
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of a genetically defined ultra-high-risk group in relapsed pediatric T-lymphoblastic leukemia.
    Richter-Pechańska P; Kunz JB; Hof J; Zimmermann M; Rausch T; Bandapalli OR; Orlova E; Scapinello G; Sagi JC; Stanulla M; Schrappe M; Cario G; Kirschner-Schwabe R; Eckert C; Benes V; Korbel JO; Muckenthaler MU; Kulozik AE
    Blood Cancer J; 2017 Feb; 7(2):e523. PubMed ID: 28157215
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chromatin accessibility landscape of pediatric T-lymphoblastic leukemia and human T-cell precursors.
    Erarslan-Uysal B; Kunz JB; Rausch T; Richter-Pechańska P; van Belzen IA; Frismantas V; Bornhauser B; Ordoñez-Rueada D; Paulsen M; Benes V; Stanulla M; Schrappe M; Cario G; Escherich G; Bakharevich K; Kirschner-Schwabe R; Eckert C; Loukanov T; Gorenflo M; Waszak SM; Bourquin JP; Muckenthaler MU; Korbel JO; Kulozik AE
    EMBO Mol Med; 2020 Sep; 12(9):e12104. PubMed ID: 32755029
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Single-cell DNA amplicon sequencing reveals clonal heterogeneity and evolution in T-cell acute lymphoblastic leukemia.
    Albertí-Servera L; Demeyer S; Govaerts I; Swings T; De Bie J; Gielen O; Brociner M; Michaux L; Maertens J; Uyttebroeck A; De Keersmaecker K; Boeckx N; Segers H; Cools J
    Blood; 2021 Feb; 137(6):801-811. PubMed ID: 32812017
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Deciphering the Clonal Origin of Relapsed Acute Lymphoblastic Leukemia in Children.
    Ogawa S
    Blood Cancer Discov; 2020 Jul; 1(1):21-22. PubMed ID: 34661139
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Late relapses evolve from slow-responding subclones in t(12;21)-positive acute lymphoblastic leukemia: evidence for the persistence of a preleukemic clone.
    Konrad M; Metzler M; Panzer S; Ostreicher I; Peham M; Repp R; Haas OA; Gadner H; Panzer-Grumayer ER
    Blood; 2003 May; 101(9):3635-40. PubMed ID: 12506024
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mutational dynamics of early and late relapsed childhood ALL: rapid clonal expansion and long-term dormancy.
    Spinella JF; Richer C; Cassart P; Ouimet M; Healy J; Sinnett D
    Blood Adv; 2018 Feb; 2(3):177-188. PubMed ID: 29365312
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.